A detailed history of Deep Track Capital, LP transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 8,585,980 shares of ADGI stock, worth $28.4 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
8,585,980
Previous 9,722,254 11.69%
Holding current value
$28.4 Million
Previous $32.2 Million 11.69%
% of portfolio
1.01%
Previous 1.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
N/A
-1,136,274 Reduced 11.69%
8,585,980 $28.4 Million
Q1 2025

May 15, 2025

SELL
N/A
-967,349 Reduced 9.05%
9,722,254 $32.2 Million
Q4 2024

Feb 14, 2025

SELL
N/A
-264,334 Reduced 2.41%
10,689,603 $35.4 Million
Q1 2024

May 15, 2024

BUY
N/A
10,953,937 New
10,953,937 $36.3 Million

Others Institutions Holding ADGI

About Adagio Therapeutics, Inc.


  • Ticker ADGI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,831,000
  • Market Cap $505M
  • Description
  • Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...
More about ADGI
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.